Last reviewed · How we verify

NCT07165860

Clinical Trial to Reduce Perinatal Intimate Partner Violence

Recruiting now NA Last updated 16 April 2026
What this trial tests

NA trial testing Doulas in Domestic Violence in 250 participants. Currently enrolling.

Timeline
1 November 2025
Primary endpoint
1 November 2028
1 May 2029

Quick facts

Lead sponsorUniversity of Pittsburgh
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment250
Start date1 November 2025
Primary completion1 November 2028
Estimated completion1 May 2029
Sites3 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Pittsburgh

Who can join

18 and older, female only, with Domestic Violence or Perinatal Problems. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a two-armed, fully powered hybrid type 1 trial to test the effectiveness of a doula intervention compared with an active control in reducing intimate partner violence (IPV) among perinatal IPV survivors

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Domestic Violence

Currently open trials in the same condition.

Other University of Pittsburgh trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07165860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing